ABSTRACT
Up to 90% of people with CF (pwCF) will have some form of hepatobiliary involvement. This manuscript aims to explore the different endovascular, endoscopic, radiological and surgical procedures available to diagnose and manage the most severe form of CF hepatobiliary involvement (CFHBI) known as advanced cystic fibrosis liver disease (aCFLD), seen in 10% of pwCF. These procedures and interventions include liver biopsy, hepatic venous pressure gradient measurement, gastrostomy tube placement to optimize nutrition, paracentesis, endoscopic variceal control of bleeding and portosystemic shunting before liver transplantation. By utilizing advanced diagnostic or surgical techniques, healthcare professionals of pwCF can more effectively manage patients with CFHBI and aCFLD and potentially improve patient outcomes.
Subject(s)
Cystic Fibrosis , Humans , Cystic Fibrosis/surgery , Cystic Fibrosis/complications , Cystic Fibrosis/diagnostic imaging , Liver Diseases/diagnostic imaging , Liver Diseases/surgery , Liver Transplantation , Endovascular Procedures/methods , Gastrostomy/methods , Portasystemic Shunt, Surgical/methods , Paracentesis/methodsABSTRACT
Remimazolam is an ultrashort acting intravenous sedative-hypnotic approved for procedural sedation. We report a series of 8 cases of radiographically placed gastrostomy tubes using remimazolam as the sole anesthetic agent. Interventional radiology (IR) gastrostomy tube placement entails anesthetizing often complex patients in a nonoperating room environment. All 8 patients reported here underwent successful gastrostomy tube placement without the need for conversion to general anesthesia. Remimazolam is a feasible option to sedate patients for gastrostomy tube placement in the IR suite.
Subject(s)
Benzodiazepines , Gastrostomy , Hypnotics and Sedatives , Humans , Gastrostomy/methods , Hypnotics and Sedatives/administration & dosage , Male , Female , Middle Aged , Aged , Benzodiazepines/administration & dosage , Radiology, Interventional , Adult , Aged, 80 and over , Intubation, GastrointestinalSubject(s)
Endosonography , Ultrasonography, Interventional , Humans , Endosonography/methods , Gastrostomy/methods , Gastrostomy/instrumentation , Male , Aged , Female , Middle AgedSubject(s)
Cutaneous Fistula , Endoscopic Mucosal Resection , Gastric Fistula , Gastrostomy , Humans , Gastric Fistula/etiology , Gastric Fistula/surgery , Gastrostomy/methods , Gastrostomy/adverse effects , Cutaneous Fistula/etiology , Cutaneous Fistula/surgery , Cutaneous Fistula/therapy , Endoscopic Mucosal Resection/methods , Endoscopic Mucosal Resection/adverse effects , Device Removal/methods , Male , Suture Techniques , Female , Aged , Middle Aged , Gastroscopy/methodsABSTRACT
PURPOSE: Hypoalbuminemia following One-Anastomosis Gastric Bypass (OAGB) surgery remains a major concern among bariatric surgeons. This study aims to assess the outcome of partial reversal to normal anatomy with gastro-gastrostomy alone in patients with refractory hypoalbuminemia following OAGB surgery. METHODS: A retrospective study was performed on patients who underwent partial reversal surgery with gastro-gastrostomy alone due to refractory hypoalbuminemia post-OAGB surgery, using data from the Iran National Obesity Surgery Database, from 2013 to 2022. RESULTS: Of 4640 individuals undergoing OAGB, 11 underwent gastro-gastrostomy due to refractory hypoalbuminemia. The median time from OAGB to partial reversal was 16.6 months and the BPL length ranged from 155 to 200 cm. The follow-up period ranged from 1 to 7 years. The mean BMI was 27.3 (7.5) kg/m² before partial reversal. The mean BMI post-reversal was 30.9 (4.2) kg/m² after 1 year and 33.3 (3.8) kg/m² after 2 years. Serum albumin levels significantly increased from 3.0 (0.4) g/dL to 4.0 (0.5) g/dL following gastro-gastrostomy (p-value < 0.001). Serum liver enzymes (SGOT, SGPT, ALP) significantly decreased post-gastro-gastrostomy (p-value < 0.05). Nine individuals (81.8%) achieved resolution of hypoalbuminemia after gastro-gastrostomy with maintenance of ≥ 20% TWL and ≥ 50% EWL. No cases of anastomotic stricture, leak, bleeding, or major complications were reported after gastro-gastrostomy. CONCLUSION: Gastro-gastrostomy appears to be a safe and efficacious technique for addressing refractory hypoalbuminemia following OAGB. The procedure preserves the weight loss achieved following OAGB without significant complications. However, further studies are required to validate these findings.
Subject(s)
Gastric Bypass , Gastrostomy , Hypoalbuminemia , Obesity, Morbid , Humans , Hypoalbuminemia/etiology , Gastric Bypass/adverse effects , Gastric Bypass/methods , Female , Male , Retrospective Studies , Adult , Gastrostomy/methods , Gastrostomy/adverse effects , Obesity, Morbid/surgery , Middle Aged , Postoperative Complications/etiology , Treatment Outcome , ReoperationSubject(s)
Anesthesia, Epidural , Gastrostomy , Humans , Gastrostomy/methods , Anesthesia, Epidural/methods , Male , Female , Middle Aged , Airway Management/methods , Thoracic VertebraeABSTRACT
Numerous patients stand to gain significant health benefits from enteral nutrition support facilitated by percutaneous feeding tubes. Consequently it is crucial for endoscopists, general practitioners, surgeons and neurologists to be well-versed with indications, contraindications and potential complications of PEG and other enteral feeding tubes. In this context we present a concise overview of the new national guidelines by the Swedish Society of Gastroenterology regarding the management of PEG and other enteral feeding tubes. Indications for the use of enteral feeding tubes include conditions such as stroke and obstructive cancer. The care of patients with percutaneous feeding tubes necessitates the expertise of a specialized team. Complications related to PEG include, among others, buried bumper syndrome, local infection and dislocation of the feeding tube.
Subject(s)
Enteral Nutrition , Gastrostomy , Practice Guidelines as Topic , Humans , Enteral Nutrition/instrumentation , Enteral Nutrition/methods , Gastrostomy/methods , Gastrostomy/adverse effects , Gastrostomy/instrumentation , Sweden , Intubation, Gastrointestinal/instrumentation , Intubation, Gastrointestinal/adverse effects , GastroscopyABSTRACT
Sleeve gastrectomy (SG) is widely recognized as the leading bariatric procedure worldwide. However, leakage, its major complication, remains a significant concern. This study focuses on the challenges of managing leakage, especially when conventional endoscopic treatments are ineffective. Although a novel one-step approach as reported by Pulimuttil James Zachariah from Wei-Jei Lee's team has demonstrated promise, further investigations and reports on its efficacy are currently insufficient. Between January 2021 and November 2023, we analyzed five patients treated at our center for SG leakage. Patient data include demographics, comorbidities, surgical details, and outcomes. The study details Laparo-Endoscopic Gastrostomy procedures performed post-SG leakage diagnosis, highlighting differences between acute and chronic instances. The study effectively implemented Zachariah's one-step approach, achieving favorable results in all five cases. Patient characteristics, presentation, postoperative progression, and additional treatments were documented. The outcome supports Zachariah's assertion that the one-step approach is a simple, safe, and cost-effective approach for SG leakage, avoiding digestive tract reconstruction. Despite potential limitations, including challenges in closing large defects and extended healing times, the procedure's effectiveness in decompression, drainage, and nutritional support significantly contributes to its elevated healing rate. The study emphasizes the importance of timely abdominal drain removal based on clinical conditions, challenging traditional practices for better clinical outcomes.
Subject(s)
Anastomotic Leak , Gastrectomy , Gastrostomy , Laparoscopy , Obesity, Morbid , Humans , Female , Gastrectomy/methods , Gastrectomy/adverse effects , Adult , Obesity, Morbid/surgery , Male , Anastomotic Leak/surgery , Anastomotic Leak/etiology , Gastrostomy/methods , Middle Aged , Laparoscopy/methods , Treatment Outcome , Bariatric Surgery/methods , Bariatric Surgery/adverse effectsABSTRACT
BACKGROUND: Meta-analysis of 10 randomized prospective trials demonstrated a higher risk of postoperative bleeding from pancreaticogastrostomy (PG) compared with pancreatojejunostomy following pancreatoduodenectomy (PD). This study evaluated the incidence, risk factors, and treatment of anastomotic bleeding from invaginated PG. METHODS: We retrospectively evaluated all consecutive PDs performed between April 1, 2011 and December 31, 2022 using invaginated PG by the double purse-string technique. Multivariate analysis identified risk factors for anastomotic PG bleeding. RESULTS: During the study, 695 consecutive patients with a median age of 66 years underwent PD; the majority was performed for ductal pancreatic adenocarcinomas. Simultaneous vascular resections were performed in 328 patients. Postoperative mortality was 4.1%. Bleeding from PG occurred in 33(4.6%) patients at a median interval of 5 days (range, 1-14) from surgery, leading to reoperation in 21(63%). PG bleeding-related mortality was 9.0%. Multivariate analyses identified a soft pancreatic texture and Wirsung duct > 3 or ≤ 3 mm (Class C and D, respectively, of the ISGPS) (odds ratio [OR]: 2.17, 95% confidence interval [95% CI]: 1.38-3.44; P = 0.0009) and wrapping of the invaginated pancreas (OR: 0.37, 95% CI: 0.17-0.84; P = 0.01) as independent risk factors for PG bleeding. CONCLUSIONS: In a large volume setting, anastomotic bleeding from invaginated PG occurred in ~ 5% of patients and was associated with soft pancreatic parenchyma and small wirsung duct. The reduced rate of PG bleeding observed with wrapping of the invaginated pancreatic stump warrants further evaluation in a prospective randomized study.
Subject(s)
Gastrostomy , Pancreaticoduodenectomy , Postoperative Hemorrhage , Humans , Pancreaticoduodenectomy/adverse effects , Male , Female , Aged , Postoperative Hemorrhage/etiology , Middle Aged , Risk Factors , Incidence , Retrospective Studies , Gastrostomy/adverse effects , Gastrostomy/methods , Pancreatic Neoplasms/surgery , Anastomosis, Surgical/adverse effects , Anastomosis, Surgical/methods , Aged, 80 and over , Adult , Pancreas/surgerySubject(s)
Cutaneous Fistula , Diarrhea , Gastrostomy , Intestinal Fistula , Tomography, X-Ray Computed , Humans , Gastrostomy/adverse effects , Gastrostomy/methods , Intestinal Fistula/etiology , Intestinal Fistula/surgery , Intestinal Fistula/diagnostic imaging , Cutaneous Fistula/etiology , Cutaneous Fistula/surgery , Cutaneous Fistula/diagnostic imaging , Diarrhea/etiology , Male , Colonic Diseases/surgery , Colonic Diseases/etiology , Endoscopy, Gastrointestinal/methods , Female , Middle AgedSubject(s)
Endosonography , Stents , Ultrasonography, Interventional , Humans , Endosonography/methods , Gastrostomy/methods , Male , Anastomosis, Surgical/methods , Aged , FemaleSubject(s)
Cholestasis , Endosonography , Peritonitis , Humans , Endosonography/methods , Peritonitis/etiology , Peritonitis/surgery , Cholestasis/etiology , Cholestasis/surgery , Male , Ultrasonography, Interventional , Bile Duct Neoplasms/surgery , Bile Duct Neoplasms/complications , Aged , Anastomosis, Surgical/adverse effects , Gastrostomy/adverse effects , Gastrostomy/methods , Female , Middle AgedSubject(s)
Gastrostomy , Pancreatic Fistula , Pancreaticojejunostomy , Postoperative Complications , Humans , Pancreatic Fistula/etiology , Pancreaticojejunostomy/methods , Pancreaticojejunostomy/adverse effects , Postoperative Complications/etiology , Gastrostomy/methods , Gastrostomy/adverse effects , Pancreatectomy/adverse effects , Pancreatectomy/methods , Meta-Analysis as TopicABSTRACT
Objective: To investigate the effectiveness and safety of multimodal analgesia in patients with end-stage head and neck cancer in open gastrostomy surgery. Methods: This was a randomized controlled trial. From June to December 2023, 50 patients with end-stage head and neck cancer who underwent elective open gastrostomy surgery in Beijing Tongren Hospital Affiliated to Capital Medical University were prospectively selected. The patients were divided into multimodal analgesia group and local anesthesia group using the random number table method according to different anesthesia methods, with 25 cases in each group. In multimodal analgesia group, a multimodal analgesia regimen was adopted: ultrasound-guided abdominal wall nerve block (rectus sheath block and transverse abdominis plane block)+intravenous injection of oxycodone+intravenous injection of flurbiprofen axetil and dexamethasone. In local anesthesia group, local infiltration anesthesia with ropivacaine was adopted. The main outcome measure was the incidence of intraoperative pain numeric rating scale (NRS) score>3 points in the two groups. The secondary observation indicators included NRS score and hemodynamic indexes [mean arterial pressure (MAP) and heart rate (HR)] at various time points during surgery [before anesthesia (T0), at the time of incision (T1), 10 minutes after surgery (T2), during gastric body traction (T3), and at the end of surgery (T4)], incidence of adverse reactions, postoperative patient satisfaction score, as well as the NRS scores at rest and activity (coughing) within 24 hours after surgery. Results: The multimodal analgesia group included 21 males and 4 females, aged (61.4±9.9) years. There were 19 males and 6 females in the local anesthesia group, aged (58.6±10.8) years. The incidence of intraoperative NRS score>3 points and the incidence of salvage analgesia in the multimodal analgesia group were both 12.0% (3/25), which were lower than 60.0% (15/25) in the local anesthesia group, and the differences were statistically significant (all P<0.001); The NRS score [M (Q1, Q3)] at T3 in the multimodal analgesia group was 2 (2, 3) points, which were lower than 5 (3, 6) points in the local anesthesia group (P<0.05). There were smaller variabilities in MAP and HR in the multimodal analgesia group than those in the local anesthesia group (all P<0.05). The incidence of intraoperative tachycardia, surgical traction reaction, and nausea in the multimodal analgesia group was lower than that in the local anesthesia group (all P<0.05). The postoperative satisfaction score of patients in the multimodal analgesia group was (9.25±0.71) points, which were higher than (7.33±0.87) points in the local anesthesia group (P<0.001). NRS score during postoperative activity within 24 hours in the multimodal analgesia group were (2.36±0.75) points, which were lower than (3.03±0.81) points of the local anesthesia group (P=0.005). No adverse reactions such as urinary retention, nausea, vomiting and dizziness occurred in both groups. Conclusion: Compared with local anesthesia, the multimodal analgesic strategy could provide better analgesic effect and longer duration, better hemodynamic stability, and fewer intraoperative adverse reactions in patients with end-stage head and neck cancer undergoing open gastrostomy.
Subject(s)
Analgesia , Gastrostomy , Head and Neck Neoplasms , Nerve Block , Humans , Head and Neck Neoplasms/surgery , Analgesia/methods , Nerve Block/methods , Gastrostomy/methods , Male , Anesthesia, Local , Pain, Postoperative , Female , Pain Management/methods , Prospective Studies , Anesthetics, Local/administration & dosage , Middle Aged , Pain MeasurementABSTRACT
Tract dilation prior to stent placement is an important step in endoscopic ultrasound-guided hepaticogastrostomy. Mukai and colleagues describe their use of a novel catheter with a longer balloon, which enables one-step tract dilation of the gastric wall, liver parenchyma, and bile duct wall, shortening the procedure and reducing bile leakage.
Subject(s)
Endosonography , Humans , Endosonography/methods , Dilatation/instrumentation , Dilatation/methods , Anastomosis, Surgical , Gastrostomy/methods , Ultrasonography, Interventional , Catheters , Stomach/surgery , Catheterization/methods , Stents , Equipment DesignABSTRACT
Reports of pancreatic pseudocyst drainage during metabolic bariatric surgery are extremely rare. Our patient is a 38-year-old female suffering from obesity grade IV and presents a persistent symptomatic pancreatic pseudocyst 8 months after an episode of acute biliary pancreatitis. After an extensive evaluation and considering other treatment options, our multidisciplinary team and the patient decided to perform a one-stage procedure consisting of laparoscopic cystogastrostomy, cholecystectomy, and one-anastomosis gastric bypass. After bringing the patient to the operating room, the surgeon performed an anterior gastrostomy to access the stomach's posterior wall, followed by a 6-cm cystogastrostomy on both the stomach's posterior wall and the cyst. Next, a cholecystectomy which involved dissecting the triangle of Calot was performed. Then, an 18-cm gastric pouch using a 36-Fr calibration tube was created. The cystogastrostomy was left in the remaining stomach. Finally, gastrojejunal anastomosis is done. The patient's postoperative course proceeded smoothly, leading to her home discharge on the third postoperative day. At the 1-year follow-up, the patient had lost 56 kg and was symptom-free; a computer tomography scan showed that the pancreatic pseudocyst had resolved. This case shows a video of a successful laparoscopic cystogastrostomy, cholecystectomy, and one-anastomosis gastric bypass (OAGB) used to treat persistent abdominal pain and obesity grade IV. We also conduct a bibliographic review.